I doubt it, despite both companies being coking coal plays the pure difference in size means most funds that would invest in B2Y would not be in CRN and vice versa
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025